4 terminated. 4 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Terminated 4 |
Follow Hyponatremia: new trials by email Literature Review of Hyponatremia trials Research Report on Hyponatremia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tolvaptan for Advanced or Refractory Heart Failure Tolvaptan, Standard of care diuretic therapy - Heart Failure, Hyponatremia | Phase 4 | Terminated | University of Calgary | 9 | 2016-10-01 | 2020-07-27 |
| Effect of Samsca on Control of Hyponatremia and Extracellular Fluid in Cirrhotic Patients With Ascites Tolvaptan, Placebo - Hyponatremia and Extracellular Fluid in Cirrhotic | Phase 4 | Terminated | Korea Otsuka Pharmaceutical Co., Ltd. | 74 | 2012-04-01 | 2022-03-04 |
| Tolvaptan to Reduce Length of Stay in Hospitalized Patients With Cirrhosis and Hyponatremia Tolvaptan, Placebo, Hepatic Encephalopathy Assessment - Hyponatremia | Phase 4 | Terminated | NYU Langone Health | 2 | 2012-03-01 | 2017-12-11 |
| Use of Conivaptan (Vaprisol) for Hyponatremic Neuro-ICU Patients Conivaptan - Hyponatremia | Phase 4 | Terminated | Northwestern University | 6 | 2008-08-01 | 2022-03-28 |
Heart Failure (1)
Metabolic Diseases (4) · Nutritional and Metabolic Diseases (4) · Water-Electrolyte Imbalance (4) · Cardiovascular Diseases (1) · Heart Diseases (1)
Tolvaptan (3) · conivaptan (1)
Korea Otsuka Pharmaceutical Co., Ltd. (1) · NYU Langone Health (1) · Northwestern University (1) · University of Calgary (1)
Canada (1) · South Korea (1) · United States (1)
Andrew M Naidech, MD, MSPH (1) · Jonathan Howlett, MD (1) · Samuel Sigal, MD (1)